您現在的位置 :

醫療團隊

專業的醫護人員，提供最佳的醫療服務

醫師介紹

  •

周宏達醫師

眼腫瘤、黃斑部病變及黃斑部手術、高度近視併發症、複雜性視網膜手術、糖尿病視網膜病變、複雜性白內障手術
  • 國語,英語,閩南語
  • 助理教授
醫師網路掛號
直接點選進入醫師網路掛號畫面
醫師資歷
  • 現職
    • 長庚紀念醫院眼科部視網膜科主治醫師
    • 長庚紀念醫院眼科部助理教授
    • 英國利物浦大學眼腫瘤研究中心榮譽研究員 (Honorary Research Fellow)
  • 學歷
    • 國立中央大學生命科學研究所博士班
    • 高雄醫學大學醫學系
  • 經歷
    • 英國利物浦皇家醫院國家級眼腫瘤中心臨床研究員 （Clinical Fellow, June 2024 – June 2025)
    • 英國利物浦大學眼腫瘤研究中心研究員 （Research Fellow, June 2024 – June 2025)
    • 英國倫敦Moorfields眼科醫院國家級眼腫瘤中心臨床研究員 （Clinical Fellow, June 2023 – June 2024
    • 長庚紀念醫院眼科部視網膜科臨床研究員
    • 長庚紀念醫院眼科部總醫師
    • 長庚紀念醫院眼科部住院醫師
    • 台大醫院實習醫師 （最佳外科實習醫師）
    • 美國哈佛大學布萊根婦女醫院（Brigham and Women's Hospital ）臨床見習
  • 學會與認證
    • 世界眼腫瘤醫學會會員（International Society of Ocular Oncology）
    • 美國視覺與眼科研究學會（The Association for Research in Vision and Ophthalmology) 會員
    • 歐洲視網膜醫學會會員 (European Society of Retina Specialists)
    • 中華民國眼科醫學會會員
    • 台灣黃斑部醫學會會員 (Taiwan Macula Society)
    • 中華民國視網膜醫學會會員(Taiwan Retina Society)
    • 台灣白內障及屈光手術醫學會會員
    • 台灣白內障以及屈光醫學會陳明教授優秀青年眼科醫師銀牌獎 (2025)
    • 歐洲視網膜醫學會導師計畫（EURETINA Mentorship Programme, Class 2024-2025)
    • 世界眼腫瘤醫學雙年會海外研習獎金（2024）
    • 台灣眼科醫學會愛爾康優秀論文獎銀牌（2023）
    • 亞太玻璃體黃斑部醫學會領袖培育營（2021-2022）整體表現銀牌獎
    • 亞太玻璃體黃斑部醫學會領袖培育營（2021-2022）最佳原創計畫金牌獎
    • 世界眼腫瘤醫學雙年會海外研習獎金（2022）
    • 林口長庚紀念醫院最佳論文獎（2022三月）
    • 林口長庚紀念醫院最佳論文獎（2022二月）
    • 台灣黃斑部醫學年會論文競賽銀牌獎（2022）
    • 台灣白內障及屈光手術醫年會手術影片競賽銀牌獎以及最佳人氣獎（2022）
    • 亞太眼科醫學年會年輕眼科醫師論壇最佳論文報告首獎 （2021）
    • 中華民國視網膜醫學會年會手術短片競賽銀牌獎( 2021 )
    • 中華民國視網膜醫學會年會優秀論文競賽優選 （2021）
    • 台灣黃斑部醫學年會手術影片競賽銀牌獎（2021）
    • 台灣黃斑部醫學年會手術影片競賽金牌獎（2020）
    • 亞太玻璃體黃斑部醫學年會年輕眼科醫師最佳手術影片首獎（2019）
    • 林口長庚紀念醫院服務優良人員（2018）
    • 眼科教授醫學會最佳口頭報告獎(2015)
  • 論文及期刊發表
    • 眼腫瘤轉診諮詢信箱：eyetumor.chou@gmail.com

    • 眼腫瘤質子治療媒體報導（2023二月）
      https://reurl.cc/vk6bAe
    • 眼睛也會長腫瘤？長庚質子治療，逃過眼球摘除，視力保持1.0
      （長庚醫訊，第四十四卷第四期）：https://reurl.cc/NqEWKn
    • Inadvertent Scleral Perforation During Choroidal Melanoma Surgeries: Incidence, Risk Factors, Management, and Outcomes.
      Am J Ophthalmol. 2025 May 31:S0002-9394(25)00278-8. doi: 10.1016/j.ajo.2025.05.043. Epub ahead of print.(SCIE) 影響因子 = 4.2, 期刊排名 = Q1, 12/98 [ 脈絡膜黑色素瘤手術中之醫源性鞏膜穿孔：發生率、危險因子、處理及預後 ]
      Chou HD, Heimann H, Damato BE, Hussain RN.(第一作者)
    • Retinal vascular proliferation with fibrotic regression in von Hippel-Lindau disease.
      Taiwan J Ophthalmol. 2025 Mar 5;15(1):138-142. doi: 10.4103/tjo.TJO-D-24-00116. (ESCI) 影響因子 = 1.2, 期刊排名 = Q3, 69/98 [ von Hippel-Lindau disease合併之視網膜血管增生以及纖維性退化 ]
      Chen JY, Chou HD, Chao AN, Lai CC, Sagoo MS.[通訊作者]
    • Sub-Perfluorocarbon Ophthalmic Viscoelastic Injection (SPOT) technique for macular hole retinal detachment surgery.
      BMC Ophthalmol. 2025 Apr 9;25(1):190. doi: 10.1186/s12886-025-03969-1.(SCIE) 影響因子 = 1.7, 期刊排名 = Q3, 58/98 [ 使用重油下人工玻璃體注射術輔助黃斑部裂孔合併視網膜剝離之修復手術 ]
      Chou HD, Teh WM, Chen KJ, Hwang YS, Liu L, Yeung L, Wu WC, Lai CC. [第一作者]
    • Synthesis, Properties, and Biocompatibility of 4-Carboxyphenyboronic Acid-Modified Gelatin-Methacryloyl: A Hydrogel for Retinal Surgeries.
      ACS Omega. 2024 Oct 1;9(41):42147-42158. doi: 10.1021/acsomega.4c02842.(SCIE) 影響因子 = 4.3, 期刊排名 = Q2, 81/239 [ 4-羧基苯硼酸修飾明膠甲基丙烯醯胺的合成、性質與生物相容性：應用於視網膜手術的水凝膠 ]
      Chou HD, Chen CA, Liu HY, Liu SJ, Lai PL, Wu WC, Hwang YS, Chen KJ, Tsai TT, Lai CC.[第一作者]
    • Retinal vascular arcade angle as a biomarker for visual improvement after epiretinal membrane surgery.
      Eye (Lond). 2024 Mar;38(4):778-785. doi: 10.1038/s41433-023-02776-6. Epub 2023 Oct 21.(SCIE) 影響因子 = 3.2, 期刊排名 = Q1, 17/98 [ 視網膜血管角度作為黃斑部皺摺手術後視力改善的生物標記 ]
      Chou HD, Chang YC, Wu PY, Kang EY, Chen YH, Liu L, Chen KJ, Hwang YS, Chao AN, Wu WC, Lai CC. [第一作者]
    • Managing vitreoretinal complications in uveal melanoma: Surgical treatment and practical considerations.
      Semin Ophthalmol. 2024 Aug 28:1-10. doi: 10.1080/08820538.2024.2381774. (SCIE) 影響因子 = 2.3, 期刊排名 = Q2, 32/98 [ 處理葡萄膜黑色素瘤的玻璃體視網膜併發症：手術治療與臨床考量 ]
      Anguita R, Chou HD, Raval VR, Bajpai V, Ferro Desideri L, Bernardi E, Hussain RN, Kim M, Fung AT, Williams BK Jr, Di Nicola M, Sagoo MS, da Cruz L, Damato B, Kiilgaard JF. [第一作者]
    • Concomitant methicillin-resistant Staphylococcus aureus scleral buckle infection and acute retinal necrosis: A case report.
      J Fr Ophtalmol. 2024 Apr;47(4):104110. doi: 10.1016/j.jfo.2024.104110. Epub 2024 Mar 1.(SCIE) 影響因子 = 1.1, 期刊排名 = Q3, 73/98 [ 甲氧苯青黴素抗藥性金黃色葡萄球菌鞏膜扣帶感染合併急性視網膜壞死之病例報告 ]
      Chang YC, Tsao YT, Wang CT, Hwang YS, Chou HD. [通訊作者]
    • Traumatic terson syndrome with a peculiar mass lesion and tractional retinal detachment: a case report.
      BMC Ophthalmol. 2024 Apr 8;24(1):153. doi: 10.1186/s12886-024-03407-8. (SCIE) 影響因子 = 1.7, 期刊排名 = Q3, 58/98 [ 伴隨特殊眼內腫塊與牽引性視網膜剝離的創傷性 Terson 症候群：病例報告 ]
      Lin YC, Wang CT, Chen KJ, Chou HD. [通訊作者]
    • Clinical outcomes of fiducial-free proton beam therapy in Asian patients with uveal melanoma.
      Clin Exp Ophthalmol. 2023 Nov;51(8):875-878. doi: 10.1111/ceo.14299. Epub 2023 Sep 24.(SCIE) 影響因子 = 5.6, 期刊排名 = Q1, 6/98 [ 亞洲葡萄膜黑色素瘤患者接受無定位標記質子治療之臨床結果 ]
      Chou HD, Yap WK, Wang CC, Chao AN. [第一作者]
    • Surgical decisions and outcomes of rhegmatogenous retinal detachment during the coronavirus disease 2019 pandemic: Data from a tertiary referral center in Taiwan.
      Indian J Ophthalmol. 2023 Jun;71(6):2548-2554. doi: 10.4103/IJO.IJO_2513_22. (SCIE) 影響因子 = 1.8, 期刊排名 = Q3, 51/98 [ 冠狀病毒疾病疫情期間裂孔性視網膜剝離的手術決策與治療結果：來自台灣三級轉診中心的數據 ]
      Wu PY, Chou HD, Hwang YS, Kang EY, Chen YH, Liu L, Chen KJ, Wu WC, Chen HC. [第一作者]
    • Analysis of Retinol Binding Protein 4 and ABCA4 Gene Variation in Non-Neovascular Age-Related Macular Degeneration.
      Diagnostics (Basel). 2023 Jul 19;13(14):2411. doi: 10.3390/diagnostics13142411. (SCIE) 影響因子 = 3.3, 期刊排名 = Q1, 57/332 [ 乾性老年黃斑部病變中視黃醇結合蛋白4與 ABCA4 基因變異之分析 ]
      Chou HD, Hwang YS, Chen KJ, Wu WC, Liu L, Ou ST, Liao W, Wang CC, Lin T, Lai CC. [第一作者]
    • MicroRNA-152-3p and MicroRNA-196a-5p Are Downregulated When Muller Cells Are Promoted by Components of the Internal Limiting Membrane: Implications for Macular Hole Healing.
      Int J Mol Sci. 2023 Dec 6;24(24):17188. doi: 10.3390/ijms242417188.(SCIE) 影響因子 = 4.9, 期刊排名 = Q2, 133/320 [ 視網膜內限膜成分刺激 Muller 細胞時MicroRNA-152-3p 與 MicroRNA-196a-5p 之表現降低：此現象對黃斑裂孔癒合的啟示 ]
      Chou HD, Shiah SG, Chuang LH, Wu WC, Hwang YS, Chen KJ, Kang EY, Yeung L, Nien CY, Lai CC. [第一作者]
    • PEELING AND INTERNAL LIMITING MEMBRANE REPOSITION (PAIR) FOR MYOPIC FOVEOSCHISIS.
      Retina. 2023 Dec 1;43(12):2134-2138. doi: 10.1097/IAE.0000000000003516. (SCIE) 影響因子 = 2.1, 期刊排名 = Q2, 40/98 [ 使用視網膜內限膜剝離與復位手術治療高度近視黃斑部劈裂 ]
      Chou HD, Teh WM, Wu WC, Hwang YS, Chen KJ, Lai CC. [第一作者]
    • COVID-19 reduced scleral buckling training in fellows and shifted young ophthalmologists' preference toward vitrectomy: An Asia-Pacific survey.
      Clin Exp Ophthalmol. 2023 Aug;51(6):585-597. doi: 10.1111/ceo.14236. Epub 2023 May 11.(SCIE) 影響因子 = 5.6, 期刊排名 = Q1, 6/98 [ 亞太地區調查之結果：COVID-19 顯著減少鞏膜扣環手術訓練，並使年輕眼科醫師更偏好玻璃體切除術 ]
      Wu PY, Fung AT, Dave VP, Iu LPL, Sjahreza E, Chaikitmongkol V, Sivagurunathan PD, Ahn J, Misra DK, Wong CW, Chou HD. [通訊作者]
    • Traumatic macular hole repair through topical dorzolamide: A case report.
      Indian Journal of Ophthalmology - Case Reports 2023 Apr-June. 3(2):p 415-418. DOI: 10.4103/IJO.IJO_2549_22 (Non-SCI) 影響因子 = NA, 期刊排名 = NA, NA [ 使用局部多佐胺治療創傷性黃斑裂孔：病例報告 ]
      Huang, HA; Chen KJ; Lai CC; Chou HD. [通訊作者]
    • Re: Conventional internal limiting membrane peeling versus inverted flap for small-to-medium idiopathic macular hole: a randomized trial. 回應：中小型自發性黃斑部裂孔使用傳統視網膜內限膜剝離與翻轉皮瓣手術的比較：隨機試驗
      Retina. 2023 Apr 1;43(4):e25-e27. doi: 10.1097/IAE.0000000000003751.(SCIE) 影響因子 = 2.1, 期刊排名 = Q2, 40/98 [ 回應：中小型自發性黃斑部裂孔使用傳統視網膜內限膜剝離與翻轉皮瓣手術的比較：隨機試驗 ]
      Chou HD, Chen KJ, Hwang YS, Wu WC, Lai CC*.
    • INTERNAL LIMITING MEMBRANE PEELING AND REPOSITION (PAIR) FOR MYOPIC FOVEOSCHISIS. 使用視網膜內限膜剝離與復位手術治療高度近視黃斑部劈裂
      Retina. 2022 May 3. Epub ahead of print.
      Chou HD, Teh WM, Wu WC, Hwang YS, Chen KJ, Lai CC*.
    • Single-layer Inverted Internal Limiting Membrane Flap Versus Conventional Peel for Small- or Medium-sized Full-thickness Macular Holes
      Am J Ophthalmol. 2022 Mar;235:111-119. doi: 10.1016/j.ajo.2021.08.016. Epub 2021 Sep 9.(SCIE) 影響因子 = 4.2, 期刊排名 = Q1, 12/98 [ 中小型黃斑部裂孔使用傳統視網膜內限膜剝離與單層內線膜翻轉皮瓣手術的比較 ]
      Chou HD, Liu L, Wang CT, Chen KJ, Wu WC, Hwang YS, Chen YP, Kang EY, Chen YH, Yeung L, Lai CC*[第一作者]
    • Optical coherence tomography and imaging biomarkers as outcome predictors in diabetic macular edema treated with dexamethasone implant.
      Sci Rep. 2022 Mar 9;12(1):3872. doi: 10.1038/s41598-022-07604-7. (SCIE) 影響因子 = 3.9, 期刊排名 = Q1, 25/135 [ 光學同調斷層掃描與影像生物標記作為接受地Dexamethasone植入治療之糖尿病黃斑水腫預後指標 ]
      Chou HD, Wu CH, Chiang WY, Chen NN, Hwang YS, Chen KJ, Lai CH, Wu PC, Chen YH, Yeung L, Shao SC, Lai CC, Wu WC. [第一作者]
    • Postvitrectomy endophthalmitis caused by Morganella morganii: a case report and literature review.
      BMC Infect Dis. 2022 Mar 18;22(1):265. doi: 10.1186/s12879-022-07248-y.(SCIE) 影響因子 = 3, 期刊排名 = Q2, 48/137 [ 視網膜切除手術後Morganella morganii導致之眼內炎：案例報報告以及文獻回顧 ]
      Wang CT, Chang YH, Chen KJ, Chou HD*(通訊作者)
    • Cognitive Outcomes Following Intravitreal Bevacizumab for Retinopathy of Prematurity: 4- to 6-Year Outcomes in a Prospective Cohort
      Am J Ophthalmol. 2022 Feb;234:59-70. doi: 10.1016/j.ajo.2021.06.034. Epub 2021 Jul 17.(SCIE) 影響因子 = 4.2, 期刊排名 = Q1, 12/98 [ 早產兒視網膜病變使用眼內抗血管新生藥物治療後四至六年的認知發育狀況：前瞻性研究 ]
      Chou HD, Shih CP, Huang YS, Liu L, Lai CC, Chen KJ, Hwang YS, Wu WC*[第一作者]
    • Epstein-Barr Virus Retinitis in an Immunocompromised Child: A Case Report.
      Eur J Ophthalmol. 2021 Sep;31(5):NP83-NP87. doi: 10.1177/1120672120926855.(SCIE) 影響因子 = 1.4, 期刊排名 = Q3, 61/98 [ 免疫功能低下兒童之Epstein-Barr病毒視網膜炎：病例報告 ]
      Chou HD, Teh WM, Sun MH, Chen KJ*[第一作者]
    • Clinical course of lens capsule fragment adherent to the posterior corneal surface after cataract surgery.
      Int Ophthalmol. 2021 Mar;41(3):907-914. doi: 10.1007/s10792-020-01646-4. Epub 2020 Nov 16. (SCIE) 影響因子 = 1.4, 期刊排名 = Q3, 61/98 [ 白內障手術後水晶體囊袋黏貼於角膜後表面之臨床病程 ]
      Chou HD, Hou CH, Lee JS, Hsiao CH*[第一作者]
    • Nasal or Temporal Internal Limiting Membrane Flap Assisted by Sub-Perfluorocarbon Viscoelastic Injection for Macular Hole Repair.
      Am J Ophthalmol. 2021 Mar;223:296-305. doi: 10.1016/j.ajo.2020.09.023. Epub 2020 Sep 18.(SCIE) 影響因子 = 4.2, 期刊排名 = Q1, 12/98 [ 使用重油下人工玻璃體注射術輔助之顳側或鼻側內限膜翻轉皮瓣手術治療黃斑部裂孔 ]
      Chou HD, Chong YJ, Teh WM, Chen KJ, Liu L, Chen YP, Yeung L, Hwang YS, Wu WC, Lai CC*.[第一作者]
    • Eye irrigation as a first-line treatment and diagnostic method for emergency department patients who complain of ocular foreign bodies
      Sci Rep. 2021 Dec 3;11(1):23386. doi: 10.1038/s41598-021-02989-3.(SCIE) 影響因子 = 3.9, 期刊排名 = Q1, 25/135 [ 使用眼睛盥洗作為急診主訴有異物進入眼睛病患之第一線治療及診斷方式 ]
      Chou HD, Chen KJ, Kang EY, Lin JY, Yeh PH, Chen YT, Cheng CT, Lai CC, Wu WC, Hwang YS, Hsiao CH*.[第一作者]
    • Myopia in school-aged children with preterm birth: the roles of time spent outdoors and serum vitamin D.
      Br J Ophthalmol. 2021 Apr;105(4):468-472. doi: 10.1136/bjophthalmol-2019-315663. Epub 2020 Jun 19.(SCIE) 影響因子 = 3.5, 期刊排名 = Q1, 15/98 [ 有早產病史之學齡兒童戶外活動時間、維他命D、以及近視之關聯性研究 ]
      Chou HD, Yao TC, Huang YS, Huang CY, Yang ML, Sun MH, Chen HC, Liu CH, Chu SM, Hsu JF, Chen KJ, Hwang YS, Lai CC, Wu WC*[第一作者]
    • Short-term efficacy of intravitreal Aflibercept injections for retinal angiomatous proliferation.
      BMC Ophthalmol. 2017 Jun 27;17(1):104. doi: 10.1186/s12886-017-0497-0.(SCIE) 影響因子 = 1.7, 期刊排名 = Q3, 58/98 [ 玻璃體內注射 Aflibercept 治療視網膜血管增生之短期療效評估 ]
      Chou HD, Wu WC, Wang NK, Chuang LH, Chen KJ, Lai CC*.[第一作者]
    • Early-stage multifocal candida chorioretinitis in an immunocompromised woman
      Ophthalmol Retina 2019;3(10):887.
      Chen KJ*, Chou HD, Teh WM
    • Sub-perfluoro-n-octane Injection of Ocular Viscoelastic Device Assisted Inverted Internal Limiting Membrane Flap for Macular Hole Retinal Detachment Surgery: A Novel Technique.
      BMC Ophthalmol. 2020 Mar 21;20(1):116. (SCI 2020; IF=2.209; Ophthalmology 40/62=64.5%)
      Lai CC*, Wu AL, Chou HD, Teh WM, Chen KJ, Chen YP, Liu L, Hwang YS, Wu WC.
    • Enterococcus faecalis Endophthalmitis: Clinical Settings, Antibiotic Susceptibility, and Management Outcomes.
      Microorganisms. 2021 Apr 24;9(5):918. (SCI 2020; IF=4.128; Microbiology 52/137=37.9%)
      Chen KJ, Lai CC, Chen HC, Chong YJ, Sun MH, Chen YP, Wang NK, Hwang YS, Chao AN, Wu WC, Yeung L, Sun CC, Liu L, Chen YH, Chou HD
    • Susceptibility of bacterial endophthalmitis isolates to vancomycin, ceftazidime, and amikacin.
      Sci Rep. 2021 Aug 5;11(1):15878. (SCI 2020; IF=4.379; Multidisciplinary 17/72=23.6%)
      Chen KJ*, Sun MH, Hou CH, Chen HC, Chen YP, Wang NK, Liu L, Wu WC, Chou HD, Kang EY, Lai CC.
    • Role of growth factors and internal limiting membrane constituents in muller cell migration.
      Exp Eye Res. 2021 Jan;202:108352. (SCI 2020; IF=3.467; Ophthalmology 17/62=27.4%)
      Wu AL, Liu YT, Chou HD, Chuang LH, Chen KJ, Chen YP, Liu L, Yeung L, Wang NK, Hwang YS, Wu WC, Lai CC*.
    • Trocar Blade-assisted Scleral Fixation for an Incomplete Dislocated Intraocular Lens.
      J Cataract Refract Surg. 2021 Jan. Epub ahead of print. (SCI 2020; IF=3.351; Ophthalmology 21/62=29.0%)
      Liu L, Wang NK, Chen YP, Chen KJ, Chou HD, Kang EY, Yeung L, Hwang YS, Chen TL, Chen YH, Wu WC, Lai CC, Liu JH.
    • A survey of young ophthalmologists' perception of training in Asia during COVID-19.
      Ann Acad Med Singap. 2021 Sep;50(9):729-732. (SCI 2020; IF=2.473; Medicine, General and Internal 76/169=44.9%)
      Yong WWD, Koh TCV, Shen L, Misra DK, Leung WYJ, Chandrasekaran S, Chou HD, Ang HNM, Wong CW*
    • Comparison between oral and intravenous ultrawide-field fluorescein angiography in the clinical follow-up of children with a history of retinopathy of prematurity or prematurity.
      Retina. 2022 Jul 1;42(7):1330-1337.
      Ling XC, Chou HD, Liu L, Wang NK, Lai CC, Chen KJ, Hwang YS, Wu WC*.
    • Concomitant post-traumatic ocular and cerebral fat embolism syndrome and thrombotic pulmonary embolism: A case report.
      Medicine (Baltimore). 2022 Jun 17;101(24):e29331.
      Li YS, Liu YH, Chou HD, Tseng HJ, Fu YC, Liu WC*.
    • Infection Sources and Klebsiella pneumoniae Antibiotic Susceptibilities in Endogenous Klebsiella Endophthalmitis.
      Antibiotics (Basel). 2022 Jun 27;11(7):866.
      Chen KJ*, Chen YP, Chen YH, Liu L, Wang NK, Chao AN, Wu WC, Hwang YS, Chou HD, Kang EY, Chen YT, Sun MH, Lai CC.
    • Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF)
      Prog Retin Eye Res. 2021 Nov 9:101018. Epub ahead of print. (SCI 2020; IF=21.198; Ophthalmology 1/62=1.6%)
      Tsai AS, Chou HD, Ling XC, Al-Khaled T, Valikodath N, Cole E, Yap VL, Chiang MF, Chan RVP, Wu WC*.
    • Epidemiology, Treatment, and Outcomes of Juvenile Idiopathic Arthritis-Associated Uveitis: A Multi-Institutional Study in Taiwan.
      Ocul Immunol Inflamm. 2023 Jan 25:1-9. Epub ahead of print.
      Wu PY, Kang EY, Chen WD, Chiang WY, Wu CH, Wu CY, Chen KJ, Wu WC, Chou HD, Chao AN, Hwang YS*
    • Persistent Vascular Anomalies in Retinopathy of Prematurity Children: Ultrawide-field Fluorescein Angiography Findings until School Age
      Ophthalmol Sci. 2023 Feb 7;3(3):100281
      Ling XC, Kang EY, Huang JL, Chou HD, Liu L, Lai CC, Chen KJ, Hwang YS, Wu WC
    • Retinotomies and retinectomies: A review of indications, techniques, results, and complications.
      Surv Ophthalmol. 2023 Nov-Dec;68(6):1038-1049.
      Ramamurthy SR, Dave VP, Chou HD, Ozdek S, Parolini B, Dhawahir-Scala F, Wu WC, Ribot FM, Chang A, Ruamviboonsuk P, Pathengay A, Pappuru RR
    • Findings of Retinal Venous Donut-Shaped Loop in Diabetic Retinopathy.
      Ophthalmol Retina. 2023 Nov;7(11):964.
      Chen KJ, Chou HD, Yu-Chuan Kang E.
    • Vitreous substitutes and tamponades - A review of types, applications, and future directions.
      Indian J Ophthalmol. 2024 Aug 1;72(8):1102-1111.
      Shettigar MP, Dave VP, Chou HD, Fung A, Iguban E, March de Ribot F, Zabala C, Hsieh YT, Lalwani G.
    • A comparative study of stereopsis in term and preterm children with and without retinopathy of prematurity
      Graefes Arch Clin Exp Ophthalmol. 2024 Aug;262(8):2685-2694.
      Kang EY, Chong YJ, Chen KJ, Chou HD, Liu L, Hwang YS, Lai CC, Wu WC.
    • Reshaping vitreoretinal surgery: Intraoperative optical coherence tomography as a tool for enhancing surgical decision-making in complex cases.
      Taiwan J Ophthalmol. 2024 Dec 5;14(4):619-623.
      Chang YH, Tan GSW, Chou HD, Tsai ASH
    • PRESENTATIONS AND FACTORS AFFECTING OUTCOME OF RHEGMATOGENOUS RETINAL DETACHMENT WITH CHOROIDAL DETACHMENT: An Indo-Taiwanese Study.
      Retina. 2024 Feb 1;44(2):255-260.
      Dave VP, Chou HD, Kiri H, Ieng FC, Hwang YS, Wu WC, Chen KJ, Das AV, Pathengay A, Pappuru RR, Lai CC.
    • Surgical Management of Full-Thickness Macular Holes in Macular Telangiectasia Type 2: A Global Multicenter Study
      Ophthalmology. 2024 Jan;131(1):66-77
      Park JG, Adrean SD, Begaj T, Capone A Jr, Charles S, Chen SN, Chou HD, Cohen MN, Corona ST, Faia LJ, Garg SJ, Garretson BR, Gregori NZ, Haller JA, Houghton OM, Hsu J, Jo J, Kaiser RS, Lai CC,Mahgoub MM, Mansoor M, Matoba R, Morizane Y, Nehemy MB, Raphaelian PV, Regillo CD, Ruby AJ, Runner MM, Sneed SR, Sohn EH, Spirn MJ, Vander JF, Wakabayashi T, Wolfe JD, Wykoff CC, Yonekawa Y, Yoon YH, Mahmoud TH.
    • Relations between Neurocognitive Function and Visual Acuity: A Cross-Sessional Study in a Cohort of Premature Children
      Children (Basel). 2024 Jul 25;11(8):894.
      Tu CH, Wu WC, Chin WC, Hsu SC, Tang I, Hsu JF, Chou HD, Kang EY, Huang YS.
    • ADMINISTERING INTRAVITREAL BEVACIZUMAB FOR RETINOPATHY OF PREMATURITY: 8-Year Cognitive Outcomes In A Prospective Cohort
      Retina. 2024 Nov 1;44(11):1952-1960
      Wu PL, Shih CP, Huang YS, Chen HC, Hsueh YJ, Lee CW, Chiang MC, Lien R, Lee CC, Chu SM, Chou HD, Liu L, Chen KJ, Hwang YS, Lai CC, Wu WC.
    • Retinal detachment and mortality in patients with cytomegalovirus retinitis: A multicenter study in taiwan
      Graefes Arch Clin Exp Ophthalmol. 2025 Feb;263(2):393-403.
      Wu PY, Kang EY, Chen WD, Garg SJ, Chiang WY, Lee MH, Chou HD, Wang NK, Chao AN, Chen KJ, Wu WC, Hwang YS.
    • Acute zonal occult outer retinopathy (AZOOR) complex associated with torpedo retinopathy following COVID-19 recombinant mRNA vaccination: a case report of a rare clinical presentation.
      BMC Ophthalmol. 2025 Jan 17;25(1):25.
      Chang NW, Kuo CH, Chou HD, Chen YH.
    • Evidence-based guidelines for drug dosing in intravitreal injections in silicone oil-filled eyes: Pharmacokinetics, safety, and optimal dosage.
      Surv Ophthalmol. 2. doi: 10.1016/j.survophthal.2024.09.006. Epub 2024 Sep 27.PMID: 39343316 Free article. Review.2025 Jan-Feb;70(1):96-105
      Ferro Desideri L, Sim PY, Bernardi E, Paschon K, Roth J, Fung AT, Wu XN, Chou HD, Henderson R, Tsui E, Berrocal M, Chhablani J, Wykoff CC, Cheung CMG, Querques G, Melo GB, Subhi Y, Loewenstein A, Kiilgaard JF, Zinkernagel M, Anguita R
    • Temporal Retinal Vessel Angle as a Biomarker for Familial Exudative Vitreoretinopathy
      Retina. 2025 May 7
      Qian Go CZ, Ping Chew GR, Oi-Lam Wu S, Maloof AG, Chou HD, Huang PH, Wu WC.
    • Clinicopathologic correlations and multimodal imaging of vitreoretinal metastasis from breast carcinoma.
      Eur J Ophthalmol. 2025 May 8:11206721251340582.
      Montesel A, Suresh B, Thaung C, Wagner SK, Kirkpatrick B, Chou HD, Arora A, Tucker WR, Rees A.
    • Retinitis Pigmentosa. In: Cheung GCM, Hereditary Chorioretinal Disorders.
      1st ed. Springer Nature Singapore Pte Ltd., 2020, p. 1-43.
      Chou HD, AL Wu, YC Cheng, and Wang NK.
    • Ophthalmology Resident’s Handbook.
      Chang-Gung Memorial Hospital Ophthalmology, 2017.
      Chou HD (Chief Editor) et al.
    • Vitreoretinal Surgery for Trainees.
      2nd Ed. 2021. Submacular Hemorrhage. In print
      Chou HD, Chen KJ, Wu WC, Lai CC
    • 黃斑部裂孔（Macular Hole） 眼科學綜覽，第十冊：玻璃體視網膜疾病
      2021，展元文創公司 (article in Chinese)。
      長庚醫院眼科 周宏達、賴旗俊
    • 早產兒視網膜病變（Retinopathy with Prematurity） 眼科學綜覽，第六冊：小兒眼科與斜視
      2021，展元文創公司(article in Chinese)
      長庚醫院眼科周宏達、吳為吉
    • An update from the young ophthalmologist from the Asia-Pacific Region: Taiwan Situation.
      APAO Newsletter. Jun 2020.
    • 糖尿病的眼部感染。
      糖尿病家族。2020: 81:16-18 3
      周宏達
    • 我可以裝人工電子眼嗎？
      長庚醫訊。2018:40(7):14-15
      周宏達